Who is sponsoring NCT03490435?

NCT03490435 is sponsored by Nicolaus Copernicus University.

What drugs are being tested in NCT03490435?

Interventions in NCT03490435: Tests for diagnosis of intestinal parasitic diseases.

What condition does NCT03490435 study?

NCT03490435 studies Intestinal Disease, Parasitic, Chronic Disease.

Is NCT03490435 still recruiting?

NCT03490435 is currently completed. Last updated 26 March 2020.

Last reviewed 2020-03-26 · How we verify

NCT03490435

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intestinal Parasites in Inhabitants of Kuyavian-Pomeranian Province in Poland

Completed Last updated 26 March 2020

What this trial tests

trial testing Tests for diagnosis of intestinal parasitic diseases in Intestinal Disease, Parasitic in 22 participants. Completed in 31 December 2019.

Timeline

17 February 2018

Primary endpoint
31 December 2019

31 December 2019

Quick facts

Lead sponsor	Nicolaus Copernicus University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	22
Start date	17 February 2018
Primary completion	31 December 2019
Estimated completion	31 December 2019
Sites	1 location across Poland

Drugs / interventions tested

Tests for diagnosis of intestinal parasitic diseases

Conditions studied

Intestinal Disease, Parasitic — all drugs for Intestinal Disease, Parasitic →
Chronic Disease — all drugs for Chronic Disease →

Sponsor

Nicolaus Copernicus University

Who can join

3 and older, any sex, with Intestinal Disease, Parasitic or Chronic Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of the proposed study is to assess the prevalence of intestinal parasitic diseases in adults and children. These invasions are included to "dirty hand diseases" (per os invasions), therefore it applies mainly preschool children.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Nicolaus Copernicus University trials

Trials by the same sponsor.

NCT06563921 — RE and Probiotics in MAFLD/NAFLD · NA · not yet recruiting
NCT06446258 — Assessment of the Impact of Soft Tissue Mobilization on the Scar in Patients After Cesarean Section · NA · completed
NCT06134024 — The Role of Double Pigtail Plastic Stents During Endoscopic Transmural Drainage of Pancreatic Fluid Collections. · NA · unknown
NCT06061432 — Endoscopic Ultrasound- Guided Hartmann Reversal Procedure · NA · not yet recruiting
NCT04814238 — Minimally Invasive Aortic Root and Aorta surGery rEgistry · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03490435 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nicolaus Copernicus University
Last refreshed: 26 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03490435.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing